BR0314364A - Uso de inibidores de pde iv para tratar angiogênese - Google Patents

Uso de inibidores de pde iv para tratar angiogênese

Info

Publication number
BR0314364A
BR0314364A BR0314364-3A BR0314364A BR0314364A BR 0314364 A BR0314364 A BR 0314364A BR 0314364 A BR0314364 A BR 0314364A BR 0314364 A BR0314364 A BR 0314364A
Authority
BR
Brazil
Prior art keywords
pde inhibitors
treat angiogenesis
inhibitors
pde
angiogenesis
Prior art date
Application number
BR0314364-3A
Other languages
English (en)
Inventor
Daniel A Gamache
David P Bingaman
Michael A Kapin
Original Assignee
Alcon Mfg Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Mfg Ltd filed Critical Alcon Mfg Ltd
Publication of BR0314364A publication Critical patent/BR0314364A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"USO DE INIBIDORES DE PDE IV PARA TRATAR ANGIOGêNESE". A presente invenção refere-se a inibidores de PDE-IV seletivos que são úteis para a prevenção e tratamento de distúrbios e doenças relacionados com edema/angiogênicos.
BR0314364-3A 2002-09-16 2003-09-11 Uso de inibidores de pde iv para tratar angiogênese BR0314364A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41100102P 2002-09-16 2002-09-16
PCT/US2003/028675 WO2004024085A2 (en) 2002-09-16 2003-09-11 Use of pde iv inhibitors to treat angiogenesis

Publications (1)

Publication Number Publication Date
BR0314364A true BR0314364A (pt) 2005-07-19

Family

ID=31994234

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314364-3A BR0314364A (pt) 2002-09-16 2003-09-11 Uso de inibidores de pde iv para tratar angiogênese

Country Status (14)

Country Link
US (3) US20040053939A1 (pt)
EP (1) EP1539174A4 (pt)
JP (1) JP2006501269A (pt)
KR (1) KR20050043923A (pt)
CN (1) CN1681510A (pt)
AR (1) AR041263A1 (pt)
AU (1) AU2003267161A1 (pt)
BR (1) BR0314364A (pt)
CA (1) CA2497192A1 (pt)
MX (1) MXPA05002146A (pt)
PL (1) PL374659A1 (pt)
TW (1) TW200412972A (pt)
WO (1) WO2004024085A2 (pt)
ZA (1) ZA200501477B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2851247B1 (fr) * 2003-02-19 2007-06-29 Exonhit Therapeutics Sa Methodes et compositions pour le traitement de pathologies degeneratives oculaires
SI1755616T1 (sl) * 2004-04-08 2014-04-30 Eye Co Pty Ltd. Zdravljenje eksudativne retinopatije z mineralkortikoidi
WO2007056457A2 (en) 2005-11-09 2007-05-18 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
EP2117524B8 (en) * 2007-01-29 2019-09-25 National Research Council of Canada Use of catecholamines and related compounds as anti-angiogenic agents

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570579B1 (fr) * 1984-09-26 1987-01-09 Salomon Sa Dispositif de fermeture et de serrage d'une chaussure de ski a ouverture arriere
US4975537A (en) * 1985-10-23 1990-12-04 The Upjohn Company Δ9(11) -angiostatic steroids
US4771042A (en) * 1985-11-25 1988-09-13 The Upjohn Company Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments
GB9413975D0 (en) * 1994-07-11 1994-08-31 Fujisawa Pharmaceutical Co New heterobicyclic derivatives
US5605914A (en) * 1993-07-02 1997-02-25 Celgene Corporation Imides
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
AU6823098A (en) * 1997-02-28 1998-09-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists
US5866872A (en) * 1997-07-25 1999-02-02 Hypertherm, Inc. Plasma arc torch position control
DE19812515A1 (de) * 1998-03-21 1999-09-23 M & F Entw & Patentverwertungs Lamellenschleifwerkzeug
HK1042896A1 (zh) * 1998-09-29 2002-08-30 藤泽药品工业株式会社 吡啶并吡嗪化合物的新的盐及其结晶
US6740664B2 (en) * 1998-09-30 2004-05-25 Alcon, Inc. Methods for treating otic and ophthalmic infections
US6326888B1 (en) * 1998-12-17 2001-12-04 Ching-Yung Wang Auxiliary safety warning light system for a vehicle
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
AR030345A1 (es) * 2000-08-14 2003-08-20 Alcon Inc Metodo de tratamiento de desordenes relacionados con angiogenesis

Also Published As

Publication number Publication date
AU2003267161A1 (en) 2004-04-30
US20060014782A1 (en) 2006-01-19
MXPA05002146A (es) 2005-05-23
PL374659A1 (en) 2005-10-31
EP1539174A4 (en) 2006-10-25
WO2004024085A3 (en) 2004-04-29
KR20050043923A (ko) 2005-05-11
CA2497192A1 (en) 2004-03-25
TW200412972A (en) 2004-08-01
AR041263A1 (es) 2005-05-11
US20050277648A1 (en) 2005-12-15
ZA200501477B (en) 2006-10-25
WO2004024085A2 (en) 2004-03-25
US20040053939A1 (en) 2004-03-18
CN1681510A (zh) 2005-10-12
JP2006501269A (ja) 2006-01-12
EP1539174A2 (en) 2005-06-15

Similar Documents

Publication Publication Date Title
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
ECSP045520A (es) Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos
UY28931A1 (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
NO20034056D0 (no) Proliferative sykdommer
AU5584901A (en) Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
SE9703693D0 (sv) Novel combination
PT1485127E (pt) Administração de agentes para o tratamento de inflamação
BRPI0518228A (pt) inibidores de cinesina mitótica e métodos de uso destes
PA8493701A1 (es) Compuestos para tratar la obesidad
BR0114913A (pt) Inibidores de metaloproteinase de espiro-pirimidina-2,4,6-triona
TR200401545T4 (tr) NOSS inhibitörü ilaçların amalatı için ikame imidazo [1,2-a]piridin-,-pirimidin- ve-pirazin-3-amin-türevlerinin kullanımı
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
ECSP045156A (es) Derivados de indolilalquilamina como ligandos 5-hidroxitriptamina-6
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
BR0111892A (pt) Bis-arilsulfonas
BRPI0411864A (pt) combinação de inibidores de src quinase e agentes quimioterápicos para o tratamento de doenças proliferativas
CY1119190T1 (el) Χρηση αναστολεων της il-18 για αγωγη ή προληψη βλαβων του κνς
ATE439363T1 (de) Imidazo 2,1-b -1,3,4-thiadiazole sulfonamides
BR0311903A (pt) Tratamento para depressão e ansiedade pela combinação de um inibidor de pde iv e um agente antidepressivo ou ansiolìtico
MXPA02011921A (es) Inhibidores de dipeptidasa acida n-acetilada-alfa-enlazada para el tratamiento de trastornos retinianos y glaucona.
BR0008603A (pt) Método para tratamento de copd
BR0314364A (pt) Uso de inibidores de pde iv para tratar angiogênese
BRPI0508333A (pt) uso de um composto de vitamina d, método de prevenir e/ou tratar cistite intersticial, formulação farmacêutica, composto de vitamina d, e, kit
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
BR0011363A (pt) Quimera il6ril6 para o tratamento de doenças neurodegenerativas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.